Nutrients and cofactors
Conceptual educational illustration of Proline in a glass specimen jar, labelled MOLECULE PROFILE.

View full illustrationSave Proline

AGENT PROFILE

Proline

Nonpeptide agent

Structural collagen amino acid and participant in cell metabolism.

Sources checked · October 16, 2026

Published for review · Scientific, medical, translation and citation review pending. Reported uses are not authorized indications. Frequency reflects mentions in supplied sources, not sales or global clinical prevalence.

Identity and synonyms

Catalog label is recorded; analytical identity and equivalence are not established.

Nonpeptide agent · Amino acid or derivative

Detailed molecular class: Nonpeptide agent; see mechanism for subtype

Supplied sequence or chemical reference

PubChem CID: 145742

Molecular formula: C5H9NO2

IUPAC: (2S)-pyrrolidine-2-carboxylic acid

Source: PC-PROLINE

PubChem

Chemical structure reference

Database chemical reference; does not certify supplier vial, salt, isomer or formulation.

Mechanism

Structural collagen amino acid and participant in cell metabolism.

Evidence and critical reading

Reported scientific and empirical uses

Replacement and nutritional context · Recovery and connective tissue · Skin, hair and cosmetics

Included in recovery/skin blends; being a collagen component does not prove administration regenerates tissue.

Human evidence

Collagen-supplement or cell-experiment results are not attributable to isolated proline. No injectable clinical repair regimen was verified here.

Preclinical evidence

Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.

Critical reading and limitations

Collagen-supplement or cell-experiment results are not attributable to isolated proline. No injectable clinical repair regimen was verified here.

Collagen-supplement or cell-experiment results are not attributable to isolated proline. No injectable clinical repair regimen was verified here.

Source-specific regimens

Descriptive source observations, not individual recommendations.

Regulatory product labeling

No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.

Human-study exposure

No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.

Empirical handbook

No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.

Regulation and safety

Jurisdiction-specific regulatory context

This record does not verify FDA/EMA authorization of the commercial identity. Where a specific medicine/product exists, jurisdiction/indication are detailed in cited sources; they do not transfer to supplier material.

Adverse effects and unknowns

Distinguish nutritional need from pharmacologic intervention; blend interactions/parenteral exposure remain undefined.

Contraindications

A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.

Interactions

Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.

Studies and trials

Selected studies

No selected studies are attributed in this record.

Trials attributed in the package

No trials are attributed in this record.

Trial registration does not establish efficacy or validate commercial material.

Query candidates; attribution pending

Proline · 174 unfiltered query results, not authenticated trials

Query verification: October 16, 2026

Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.

View trial registry query

NCT07020221 · A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsRegistry status: RecruitingLast update posted: October 15, 2026Query verification: October 16, 2026

NCT07547878 · Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Registry status: Enrolling by invitationLast update posted: October 13, 2026Query verification: October 16, 2026

NCT05400733 · Prandial Metabolic Phenotype in AdultsRegistry status: Active, not recruitingLast update posted: October 5, 2026Query verification: October 16, 2026

Source issues and references

References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.

  1. PC-PROLINE

    PubChem L-proline (CID 145742)

    October 16, 2026

  2. SEARCH-PUBMED-proline

    PubMed/MED targeted search: TITLE_ABS:proline AND TITLE_ABS:supplementation AND TITLE_ABS:human

    October 16, 2026

  3. pdf09

    PeptideFactory.pdf

    October 16, 2026

A community-based bilingual scientific education initiative for healthcare professionals and the general public across the Americas.Currently self-funded; no current sponsors. Formal governance and legal documentation pending.info@peptideamericas.org · Planned contact address — not active yet; please do not send messages.